FDA Approves Final Trials of MDMA as Post-Traumatic Stress Disorder Treatment
On 29 November 2016, the Food and Drug Administration opened the door to new exploration of treating post-traumatic stress disorder using the mood-altering drug methylenedioxymethamphetamine (usually shortened to MDMA and…